Mergers & Acquisitions
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Track global pharma M&A deals, divestitures, and partnerships. Gain critical intelligence for strategic investment and business development in life sciences.
Showing 1–12 of 73 articles
Quick answer
NovaPharmaNews Mergers & Acquisitions hub for FDA covers 73 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Adial Pharmaceuticals Azora merger and AT177
Socioeconomic status shapes children’s brain development, study finds
Takeda TYK2 drug tops Bristol Sotyktu
AstraZeneca expands obesity push as it invests $125M in ultrasound medicine
Tillomed Laboratories update: pipeline, melphalan and next catalysts
AbbVie Cerevel acquisition closes in $8.7B neuroscience deal
Eli Lilly Pipeline Deals and 2026 Outlook
AbbVie closes $8.7B Cerevel deal as neuroscience pipeline expands
Sanofi completes Inhibrx acquisition for $1.7B
HPN328 Merck: Harpoon deal deepens oncology
Puma Biotechnology inducement awards June 2026
McGuireWoods PE Healthcare M&A Counsel
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.